U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C72H86N12O20S
Molecular Weight 1471.587
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Orenasitecan

SMILES

CCCNC(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=CC(=CC=C2)[C@@H](CC(O)=O)NC(=O)NC3=CC=C(NC(=O)NCCOCCOCCOCCC(=O)N[C@@H](CC(O)=O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](C(C)C)C(=O)O[C@]5(CC)C(=O)OCC6=C5C=C7N(CC8=C(CC)C9=C(C=CC=C9)N=C78)C6=O)C=C3

InChI

InChIKey=NIZBSXQORMTMGG-MNFWRURASA-N
InChI=1S/C72H86N12O20S/c1-6-26-73-69(95)77-46-15-12-17-48(36-46)105(98,99)82-47-16-11-14-43(35-47)55(38-60(86)87)80-71(97)76-45-23-21-44(22-24-45)75-70(96)74-27-30-101-32-34-102-33-31-100-29-25-59(85)78-56(39-61(88)89)66(92)83-28-13-20-57(83)64(90)81-62(42(4)5)67(93)104-72(8-3)53-37-58-63-51(40-84(58)65(91)52(53)41-103-68(72)94)49(7-2)50-18-9-10-19-54(50)79-63/h9-12,14-19,21-24,35-37,42,55-57,62,82H,6-8,13,20,25-34,38-41H2,1-5H3,(H,78,85)(H,81,90)(H,86,87)(H,88,89)(H2,73,77,95)(H2,74,75,96)(H2,76,80,97)/t55-,56+,57+,62+,72+/m1/s1

HIDE SMILES / InChI

Molecular Formula C72H86N12O20S
Molecular Weight 1471.587
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 15:13:50 GMT 2025
Edited
by admin
on Wed Apr 02 15:13:50 GMT 2025
Record UNII
L3KV5NR5PG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Orenasitecan
INN  
Official Name English
(4S)-4,11-diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1Hpyrano[ 3',4':6,7]indolizino[1,2-b]quinolin-4-yl N-{1-[4-({[(1R)-2-carboxy-1-(3-{3-[(propylcarbamoyl)amino]benzene-1-sulfonamido}phenyl)ethyl]carbamoyl}amino)anilino]-1-oxo-5,8,11-trioxa-2-azatetradecan
Preferred Name English
orenasitecan [INN]
Common Name English
Code System Code Type Description
INN
13284
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
FDA UNII
L3KV5NR5PG
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
PUBCHEM
156903274
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
SMS_ID
300000056618
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
CAS
2418533-89-6
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
NCI_THESAURUS
C213405
Created by admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
PRIMARY
Related Record Type Details
TARGET->LIGAND
TOXIN -> CONJUGATE
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
VIP236 is a small molecule drug conjugate (SMDC) consisting of an alpha v beta 3 (?V?3) integrin binder linked to an optimized camptothecin (CPT) compound (VIP126), which is released by the enzyme neutrophil elastase (NE) in the tumor microenvironment (TME)